SWHR this week submitted comments in response to the National Institutes of Health (NIH) Office of Research on Women's Health (ORWH) Request for Information: Inviting Comments to Inform the Women's Health Consensus Conference (WHCC).
SWHR issued the following statement in response to the House’s Markup of the Build Back Better Act, a human infrastructure plan.
On October 18, 2021, SWHR hosted a virtual public forum where panelists discussed the health, social, and economic impacts of autoimmune skin diseases on women - as patients, as caregivers, and as both.
SWHR convened an interdisciplinary working group in September 2021 for a closed two-day roundtable meeting to discuss how to eliminate barriers to access and reduce health disparities related to treatments for infertility in women.
SWHR convened a diverse working group of clinicians, genetic counselors, patient advocates, policy professionals, and industry representatives for a three-day roundtable meeting on eliminating barriers to access and, by extension, reducing health disparities in prenatal care as they relate to ECS and NIPS.
The Society for Women’s Health Research (SWHR) published a report in the Journal of Women’s Health, capturing themes and recommendations coming […]
SWHR was invited to participate in a stakeholder meeting to inform the planning process of President Biden’s proposed Advanced Research Projects Agency for Health (ARPA-H), a new entity that would be tasked with building high-risk, high-reward capabilities or platforms to drive biomedical breakthroughs.
The Society for Women’s Health Research (SWHR) published a commentary in International Journal of Environmental Research and Public Health, presenting […]
SWHR convened a working group of public health researchers and professionals, community leaders, patient advocates, and health care providers for a closed, 1-day roundtable meeting in August 2021 to discuss eliminating barriers to information and access and reducing health disparities through the development of educational materials designed to reach women as immunization recipients and decision-makers.